Cardialysis
Private Company
Funding information not available
Overview
Cardialysis is a Netherlands-based, full-service clinical research organization (CRO) with a singular focus on cardiology. It offers end-to-end trial services from design and monitoring to data management and clinical event adjudication, complemented by a highly specialized cardiovascular imaging core laboratory. With over 40 years of operation, it has contributed to more than 400 clinical trials, establishing itself as a trusted partner for regulatory submissions (CE mark, FDA) and investigator-initiated research through its affiliated European Cardiovascular Research Institute (ECRI). The company is privately held and revenue-generating, operating as a service provider rather than a therapeutic developer.
Technology Platform
Specialized cardiovascular imaging core laboratory providing standardized, centralized analysis across multiple modalities (Angiography, Intracoronary Imaging, MRI, Echocardiography, ECG, CT) for clinical trials, supported by methodological expertise and consensus endpoint definitions.
Opportunities
Risk Factors
Competitive Landscape
Cardialysis competes with large, full-service CROs (e.g., IQVIA, PPD) that have cardiology divisions, as well as specialized cardiovascular imaging core labs (e.g., Cardiovascular Research Foundation's Core Lab, MedStar Health's Cardiovascular Core Lab). Its differentiation lies in its deep, exclusive focus on cardiology, integrated full-service offering, and strong academic heritage from the Erasmus Medical Center.